Skip Navigation


Brain Advance Access originally published online on July 7, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
126/9/2034    most recent
awg207v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wanschitz, J.
Right arrow Articles by Berger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wanschitz, J.
Right arrow Articles by Berger, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 126, No. 9, 2034-2042, September 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg207

Distinct time pattern of complement activation and cytotoxic T cell response in Guillain–Barré syndrome

Julia Wanschitz1, Hans Maier2, Hans Lassmann3, Herbert Budka4 and Thomas Berger1

Departments of 1 Neurology and 2 Pathology, University of Innsbruck, 3 Brain Research Institute and 4 Institute of Neurology, University of Vienna, Austria

Correspondence to: Dr Thomas Berger, University of Innsbruck, Department of Neurology, Anichstrasse 35, Innsbruck, A-6020 Austria E-mail: thomas.berger{at}uibk.ac.at

Humoural and cellular immune mechanisms are involved in the pathogenesis of Guillain–Barré syndrome (GBS). While activation of complement has been implicated in the initiation of myelin damage, we provide data here on the role of cellular cytotoxicity in GBS. Archival autopsy tissues including spinal roots, dorsal root ganglia and peripheral nerve were examined from 11 subjects who died 1 day to 8 weeks after onset of symptoms from GBS exhibiting a primary demyelinating pathology. In order to study the extent of humoural and cellular immune processes with regard to disease duration, a broad panel of antibodies to immunological and cellular markers was used to visualize the stage of demyelination, the deposition of complement components and expression of CD59, and to characterize cell infiltrates. Deposits of C9neo antigen on degenerating myelin sheaths were predominantly detected in acute cases. Expression of CD59 was upregulated on demyelinating fibres, but did not correlate with the presence of C9neo antigen or duration of disease. Quantitative analysis of endoneurial T cells showed a correlation between the density of CD3+ T cells per square unit and the degree of demyelination, but not with the duration of disease. The ratio of CD8+ to CD3+ T cells, however, was significantly increased in cases of GBS with a subacute course. Granzyme B positive lymphocytes and upregulation of MHC class I molecules on Schwann cells and myelin sheaths were detected in cases with more than 4 weeks disease duration. These findings implicate an important role of cytotoxic T cell responses for myelin damage in subacute stages of GBS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
H. J. WILLISON and J. J. PLOMP
Anti-ganglioside Antibodies and the Presynaptic Motor Nerve Terminal
Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 114 - 123.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. R. de Jonge, I. N. van Schaik, J. P. Vreijling, D. Troost, and F. Baas
Expression of complement components in the peripheral nervous system
Hum. Mol. Genet., February 1, 2004; 13(3): 295 - 302.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.